NAS
NVAX icon

Nykredit A/S’s Novavax NVAX Stock Holding History

Nykredit A/S’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Buy
+1,903
New +$17.1K ﹤0.01% 1761

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nykredit A/S's NVAX Position: Q2 2026 in Review

Nykredit A/S opened a new position in Novavax (NVAX) in Q2 2026: 1,903 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #1761 among its holdings.

190 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Nykredit A/S held 1,903 shares of Novavax worth $17.9K as of Q2 2026.
  • Novavax was a new Nykredit A/S position in Q2 2026.
  • Novavax made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1761 holding.
  • 190 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.